trending Market Intelligence /marketintelligence/en/news-insights/trending/kdfpmuesffjcdmvw7snu5a2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Basilea names Sanofi exec as chief technology officer

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Basilea names Sanofi exec as chief technology officer

Basel, Switzerland-based Basilea Pharmaceutica AG appointed Gerrit Hauck as its chief technology officer.

Hauck, who also joins the company's management committee, succeeds Günter Ditzinger, who will take on new responsibilities at Basilea.

Hauck previously worked at Sanofi where he was overseeing most of the company's technical development programs for synthetic molecules.

At the same time, he was a member of Sanofi's research stage gate committee, which is responsible for the transition of candidate molecules from research into development.

Additionally, Josef Künzle, head of Basilea's global quality management and a member of the extended management committee, will retire Oct. 31.

Basilea named Anne Stehlin as Künzle's successor, who joins the company from Novartis AG where she served as global head of product quality lifecycle management.

Stehlin will initially serve as Basilea's deputy head of global quality management until Oct. 31.

Basilea Pharmaceutica is focusing on the discovery, development and commercialization of products in the areas of bacterial and fungal infections and oncology.